1. |
Okamoto S, Iida O, Takahara M, et al. Impact of perioperative complications after endovascular therapy in diabetic patients with critical limb ischemia due to isolated infrapopliteal lesions. J Endovasc Ther, 2016, 23(2): 371-377.
|
2. |
Tsetis D. Endovascular treatment of complications of femoral arterial access. Cardiovasc Intervent Radiol, 2010, 33(3): 457-468.
|
3. |
Hirano Y, Ikuta S, Uehara H, et al. Diagnosis of vascular complications at the puncture site after cardiac catheterization. J Cardiol, 2004, 43(6): 259-265.
|
4. |
Banfić L, Vrkić Kirhmajer M, Vojković M, et al. Access site complications following cardiac catheterization assessed by duplex ultrasonography. Coll Antropol, 2008, 32(2): 385-390.
|
5. |
Stone PA, Campbell JE. Complications related to femoral artery access for transcatheter procedures. Vasc Endovascular Surg, 2012, 46(8): 617-623.
|
6. |
Kresowik TF, Khoury MD, Miller BV, et al. A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg, 1991, 13(2): 328-333.
|
7. |
Alvarez-Tostado JA, Moise MA, Bena JF, et al. The brachial artery: a critical access for endovascular procedures. J Vasc Surg, 2009, 49(2): 378-385.
|
8. |
Kiernan TJ, Ajani AE, Yan BP. Management of access site and systemic complications of percutaneous coronary and peripheral interventions. J Invasive Cardiol, 2008, 20(9): 463-469.
|
9. |
Hood DB, Mattos MA, Douglas MG, et al. Determinants of success of color-flow duplex-guided compression repair of femoral pseudoaneurysms. Surgery, 1996, 120(4): 585-588.
|
10. |
Birchall D, Fields JM, Chalmers N, et al. Case report: delayed superficial femoral artery pseudoaneurysm rupture following successful compression therapy. Clin Radiol, 1997, 52(8): 629-630.
|
11. |
Schneider C, Malisius R, Küchler R, et al. A prospective study on ultrasound-guided percutaneous thrombin injection for treatment of iatrogenic post-catheterisation femoral pseudoaneurysms. Int J Cardiol, 2009, 131(3): 356-361.
|
12. |
Kelm M, Perings SM, Jax T, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. J Am Coll Cardiol, 2002, 40(2): 291-297.
|
13. |
Glaser RL, McKellar D, Scher KS. Arteriovenous fistulas after cardiac catheterization. Arch Surg, 1989, 124(11): 1313-1315.
|
14. |
Perings SM, Kelm M, Jax T, et al. A prospective study on incidence and risk factors of arteriovenous fistulae following transfemoral cardiac catheterization. Int J Cardiol, 2003, 88(2-3): 223-228.
|
15. |
Altin RS, Flicker S, Naidech HJ. Pseudoaneurysm and arteriovenous fistula after femoral artery catheterization: association with low femoral punctures. AJR Am J Roentgenol, 1989, 152(3): 629-631.
|
16. |
Schaub F, Theiss W, Heinz M, et al. New aspects in ultrasound-guided compression repair of postcatheterization femoral artery injuries. Circulation, 1994, 90(4): 1861-1865.
|
17. |
Carnevale FC, De Blas M, Merino S, et al. Percutaneous endovascular treatment of chronic iliac artery occlusion. Cardiovasc Intervent Radiol, 2004, 27(5): 447-452.
|
18. |
Semaan E, Hamburg N, Nasr W, et al. Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty. Vasc Endovascular Surg, 2010, 44(1): 25-31.
|
19. |
Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med, 2008, 358(7): 689-699.
|
20. |
Scheinert D, Duda S, Zeller T, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv, 2014, 7(1): 10-19.
|
21. |
Jia X, Zhang J, Zhuang B, et al. Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt Ⅰ trial. JACC Cardiovasc Interv, 2016, 9(18): 1941-1949.
|